JF
ITOS

Jump Financial’s iTeos Therapeutics ITOS Stock Holding History

Jump Financial’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40,182
Closed -$410K – 1821
2024
Q3 		$410K Buy
40,182
+14,398
+56% +$220K 0.01% 1180
2024
Q2 		$383K Buy
+25,784
New +$369K 0.01% 1260
2024
Q1 		– Sell
-58,056
Closed -$636K – 2084
2023
Q4 		$636K Buy
+58,056
New +$576K 0.02% 931
2022
Q1 		– Sell
-41,900
Closed -$1.95M – 1714
2021
Q4 		$1.95M Buy
+41,900
New +$1.39M 0.12% 210
2021
Q3 		– Sell
-19,658
Closed -$504K – 1286
2021
Q2 		$504K Buy
+19,658
New +$468K 0.05% 473

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Jump Financial's ITOS Position: Q4 2024 in Review

Jump Financial sold out of iTeos Therapeutics (ITOS) in Q4 2024, closing a stake of 40,182 shares — an estimated $410K sold.

Jump Financial first reported a position in ITOS in Q2 2021 and held it in 5 quarters. The position peaked at $1.95M in Q4 2021. 136 funds tracked by Wall St. Rank hold ITOS as of Q4 2024.

  • Jump Financial reported no remaining iTeos Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Jump Financial sold 40,182 iTeos Therapeutics shares in Q4 2024, an estimated $410K.
  • Jump Financial first reported a position in iTeos Therapeutics in Q2 2021 and held it in 5 quarters.
  • Jump Financial's iTeos Therapeutics position peaked at $1.95M in Q4 2021.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2024.

Based on Jump Financial's 13F filing for Q4 2024, filed 13 Feb 2025.